Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2026-03-08 @ 1:07 AM
Study NCT ID:
NCT00645502
Status:
COMPLETED
Last Update Posted:
2010-04-26
First Post:
2008-03-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR002617
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None